lamotrigine

Product NDC: 69117-0044
11-digit product format: 691170044
Labeler code: 69117
Product ID: 69117-0044_47239426-3d75-73d8-e063-6294a90a608d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lamotrigine extended-release
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Yiling Pharmaceutical, Inc.
Application: ANDA213949
Marketing category: ANDA
Marketing start: 2021-12-09
Substance: LAMOTRIGINE
Active strength: 25 mg/1
Pharmacologic classes: Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69117-0044-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69117-0044-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69117-0044-2	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69117-0044-1	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69117-0044-3	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69117-0044-2	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69117-0044-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69117-0044-3	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69117-0044-2	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69117-0044-1	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69117-0044-3	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69117-0044-2	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69117-0044-1	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69117-0044-3	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69117-0044-2	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69117-0044-1	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69117-0044-3	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69117-0044-2	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A213949-001	LAMOTRIGINE	LAMOTRIGINE	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08
A213949-002	LAMOTRIGINE	LAMOTRIGINE	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08
A213949-003	LAMOTRIGINE	LAMOTRIGINE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08
A213949-004	LAMOTRIGINE	LAMOTRIGINE	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08
A213949-005	LAMOTRIGINE	LAMOTRIGINE	250MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08
A213949-006	LAMOTRIGINE	LAMOTRIGINE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-product	TE code
A213949-001	AB
A213949-002	AB
A213949-003	AB
A213949-004	AB
A213949-005	AB
A213949-006	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 204 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A213949-001	LAMOTRIGINE	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-002	LAMOTRIGINE	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-003	LAMOTRIGINE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-004	LAMOTRIGINE	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-005	LAMOTRIGINE	250MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-006	LAMOTRIGINE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A213949-001	LAMOTRIGINE	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-002	LAMOTRIGINE	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-003	LAMOTRIGINE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-004	LAMOTRIGINE	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-005	LAMOTRIGINE	250MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-006	LAMOTRIGINE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-001	LAMOTRIGINE	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-002	LAMOTRIGINE	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-003	LAMOTRIGINE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-004	LAMOTRIGINE	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-005	LAMOTRIGINE	250MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-006	LAMOTRIGINE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A213949-001	LAMOTRIGINE	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-002	LAMOTRIGINE	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-003	LAMOTRIGINE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-004	LAMOTRIGINE	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-005	LAMOTRIGINE	250MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-006	LAMOTRIGINE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-001	LAMOTRIGINE	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-002	LAMOTRIGINE	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-003	LAMOTRIGINE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-004	LAMOTRIGINE	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-005	LAMOTRIGINE	250MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-006	LAMOTRIGINE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-001	LAMOTRIGINE	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-002	LAMOTRIGINE	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-003	LAMOTRIGINE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-004	LAMOTRIGINE	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-005	LAMOTRIGINE	250MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-006	LAMOTRIGINE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213949-001	LAMOTRIGINE	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213949-002	LAMOTRIGINE	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213949-003	LAMOTRIGINE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213949-004	LAMOTRIGINE	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	2021-12-08	`03ed91905a0d…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 6 · 204 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A213949-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-005	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213949-006	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A213949-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213949-006	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213949-006	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A213949-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213949-006	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-005	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213949-006	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-004	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-005	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213949-006	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213949-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213949-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213949-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213949-004	AB	1	`03ed91905a0d…`

Additional Listing Data#

Finished product: Yes
Brand name base: lamotrigine
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LAMOTRIGINE	25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
U3H27498KS	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
850087	Internal RxNorm lookup
850091	Internal RxNorm lookup
900156	Internal RxNorm lookup
900164	Internal RxNorm lookup
1098608	Internal RxNorm lookup
1146690	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f7de11a5-5357-4753-b1ac-b15123b50028	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
14a9502b-3d70-0496-a7e1-b16edaa005b8	Product name	5	20250423
16d731ed-ff3e-e9a1-3e3e-1ef6b6be40a0	Product name	7	20250401
e29d8e8b-4bc8-ebaf-f18e-e35287b19d6a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
69117-0044-1	2024-12-30	LAMOTRIGINE extended-release tablets Yiling pharmaceutical Ltd ------------------------------------------------------------- These highlights do not include all the information needed to use LAMOTRIGINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE EXTENDED-RELEASE TABLETS. LAMOTRIGINE extended-release tablets, for oral use Initial U.S. Approval: 1994
69117-0044-2	2024-12-30	LAMOTRIGINE extended-release tablets Yiling pharmaceutical Ltd ------------------------------------------------------------- These highlights do not include all the information needed to use LAMOTRIGINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE EXTENDED-RELEASE TABLETS. LAMOTRIGINE extended-release tablets, for oral use Initial U.S. Approval: 1994
69117-0044-3	2024-12-30	LAMOTRIGINE extended-release tablets Yiling pharmaceutical Ltd ------------------------------------------------------------- These highlights do not include all the information needed to use LAMOTRIGINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE EXTENDED-RELEASE TABLETS. LAMOTRIGINE extended-release tablets, for oral use Initial U.S. Approval: 1994
69117-0044-1	2024-01-30	LAMOTRIGINE extended-release tablets Yiling pharmaceutical Ltd ------------------------------------------------------------- These highlights do not include all the information needed to use LAMOTRIGINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE EXTENDED-RELEASE TABLETS. LAMOTRIGINE extended-release tablets, for oral use Initial U.S. Approval: 1994
69117-0044-2	2024-01-30	LAMOTRIGINE extended-release tablets Yiling pharmaceutical Ltd ------------------------------------------------------------- These highlights do not include all the information needed to use LAMOTRIGINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE EXTENDED-RELEASE TABLETS. LAMOTRIGINE extended-release tablets, for oral use Initial U.S. Approval: 1994
69117-0044-3	2024-01-30	LAMOTRIGINE extended-release tablets Yiling pharmaceutical Ltd ------------------------------------------------------------- These highlights do not include all the information needed to use LAMOTRIGINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE EXTENDED-RELEASE TABLETS. LAMOTRIGINE extended-release tablets, for oral use Initial U.S. Approval: 1994

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
69117-0044-1	lamotrigine	30 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	30	7
69117-0044-2	lamotrigine	100 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	100	7
69117-0044-3	lamotrigine	500 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	500	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69117-0044	LAMOTRIGINE (LAMOTRIGINE EXTENDED-RELEASE) TABLET, FILM COATED, EXTENDED RELEASE [YILING PHARMACEUTICAL, INC.]	6	Current NDC, Legacy NDC, 3 package rows	20250101_f7de11a5-5357-4753-b1ac-b15123b50028.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
lamotrigine	LAMOTRIGINE EXTENDED-RELEASE	REMEDYREPACK INC.	65748114-c59c-4ebb-977e-d4aab5764dd3	2026-04-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213949 application number: ANDA213949
lamotrigine	LAMOTRIGINE EXTENDED-RELEASE	Camber Pharmaceuticals Inc	e45bd69f-3580-ff15-e053-2a95a90a4615	2026-02-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213949 application number: ANDA213949
lamotrigine	LAMOTRIGINE EXTENDED-RELEASE	Yiling Pharmaceutical, Inc.	f7de11a5-5357-4753-b1ac-b15123b50028	2025-12-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213949 application number: ANDA213949 ndc (product): 69117-0044
lamotrigine	LAMOTRIGINE EXTENDED-RELEASE	REMEDYREPACK INC.	70ae07a2-2f5c-4b3f-b8c7-1ac8b83c0593	2025-08-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213949 application number: ANDA213949
Lamotrigine ER	LAMOTRIGINE ER	Direct_rx	1b42a7cf-86d8-e506-e063-6394a90a3c9b	2024-06-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213949 application number: ANDA213949
lamotrigine	LAMOTRIGINE EXTENDED-RELEASE	Proficient Rx LP	39efe933-bfed-4a6a-b270-0883871c5186	2023-10-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213949 application number: ANDA213949

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U3H27498KS	LAMOTRIGINE	84057-84-1	LAMOTRIGINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
850087	lamoTRIgine 100 MG 24HR Extended Release Oral Tablet	PSN	f7de11a5-5357-4753-b1ac-b15123b50028	7
900156	lamoTRIgine 200 MG 24HR Extended Release Oral Tablet	PSN	f7de11a5-5357-4753-b1ac-b15123b50028	7
900164	lamoTRIgine 25 MG 24HR Extended Release Oral Tablet	PSN	f7de11a5-5357-4753-b1ac-b15123b50028	7
1146690	lamoTRIgine 250 MG 24HR Extended Release Oral Tablet	PSN	f7de11a5-5357-4753-b1ac-b15123b50028	7
1098608	lamoTRIgine 300 MG 24HR Extended Release Oral Tablet	PSN	f7de11a5-5357-4753-b1ac-b15123b50028	7
850091	lamoTRIgine 50 MG 24HR Extended Release Oral Tablet	PSN	f7de11a5-5357-4753-b1ac-b15123b50028	7
850087	24 HR lamotrigine 100 MG Extended Release Oral Tablet	SCD	f7de11a5-5357-4753-b1ac-b15123b50028	7
900156	24 HR lamotrigine 200 MG Extended Release Oral Tablet	SCD	f7de11a5-5357-4753-b1ac-b15123b50028	7
900164	24 HR lamotrigine 25 MG Extended Release Oral Tablet	SCD	f7de11a5-5357-4753-b1ac-b15123b50028	7
1146690	24 HR lamotrigine 250 MG Extended Release Oral Tablet	SCD	f7de11a5-5357-4753-b1ac-b15123b50028	7
1098608	24 HR lamotrigine 300 MG Extended Release Oral Tablet	SCD	f7de11a5-5357-4753-b1ac-b15123b50028	7
850091	24 HR lamotrigine 50 MG Extended Release Oral Tablet	SCD	f7de11a5-5357-4753-b1ac-b15123b50028	7
850087	lamotrigine 100 MG 24 HR Extended Release Oral Tablet	SY	f7de11a5-5357-4753-b1ac-b15123b50028	7
900156	lamotrigine 200 MG 24 HR Extended Release Oral Tablet	SY	f7de11a5-5357-4753-b1ac-b15123b50028	7
900164	lamotrigine 25 MG 24 HR Extended Release Oral Tablet	SY	f7de11a5-5357-4753-b1ac-b15123b50028	7
1146690	lamotrigine 250 MG 24 HR Extended Release Oral Tablet	SY	f7de11a5-5357-4753-b1ac-b15123b50028	7
1098608	lamotrigine 300 MG 24 HR Extended Release Oral Tablet	SY	f7de11a5-5357-4753-b1ac-b15123b50028	7
850091	lamotrigine 50 MG 24 HR Extended Release Oral Tablet	SY	f7de11a5-5357-4753-b1ac-b15123b50028	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
69117-0044-1	69117004401	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69117-0044-1)	2021-12-09	0000-00-00	No	No	Current
69117-0044-2	69117004402	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69117-0044-2)	2021-12-09	0000-00-00	No	No	Current
69117-0044-3	69117004403	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69117-0044-3)	2021-12-09	0000-00-00	No	No	Current